Skip to the page

Data / Medical devices / United States / Mallinckrodt Manufacturing LLC

Mallinckrodt Manufacturing LLC: FDA-registered device maker in Madison, WI, United States, 20 510(k) clearances

Mallinckrodt Manufacturing LLC is registered with the FDA (registration 3004531588) in Madison, WI, United States. It lists 9 device types. The FDA files 20 510(k) clearances under its listings, the newest dated December 6, 2023. 6 recall events name it as the recalling firm (1 Class I). Registered through 2026. FDA data exported November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004531588
Address
6603 Femrite Dr, Madison, WI, United States, 53718
Owner or operator
Mallinckrodt Hospital Products IP Limited (10050702)
Roles
Contract manufacturer, Manufacturer, Remanufacturer
First device listed
December 17, 2015
Registered through
2026
Brand names listed
15 M Adapter (fits 4.5 mm ID Tubing), 15M Adapter (fits 8 mm ID Tubing), Adapter , 22 mm OD X 10 mm OD, Adapter , 22F X 15M, Adapter , 22M/15F X 22M/15F, Adapter , Cuff, 22 mm ID X 22 mm ID, Adapter , Gas Sample Tee, Adapter, 90 Degree Sample Port and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
December 6, 2023K222930Evolve Nitric Oxide Delivery SystemMRNSubstantially EquivalentMallinckrodt Manufacturing, LLCaccessdata.fda.gov
April 20, 2023K211153Inomax DSIRMRNSubstantially EquivalentMallinckrodt Manufacturing, LLCaccessdata.fda.gov
July 10, 2015K143213INOmax DSIR Plus MRIMRNSubstantially EquivalentIno Therapeutics/Ikariaaccessdata.fda.gov
November 29, 2013K131686INOMAX DSIR (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeutics/Ikariaaccessdata.fda.gov
May 2, 2013K130605INOMAX DSIR (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
November 7, 2012K122689INOBLENDERMROSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
September 24, 2012K121021INOMAX DS (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
February 29, 2012K113272INOMAX DS(DELIVERY SYSTEMSMRNSubstantially EquivalentIno Therapeutics, LLC/Dba Ikariaaccessdata.fda.gov
June 24, 2011K110344INOMAX DSIR (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
June 23, 2011K110635INOMAX DS(IR) (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeutics, LLC/Dba Ikariaaccessdata.fda.gov
April 15, 2010K093922INOMAX DSMRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
March 10, 2010K092545INOMAX DS (DELIVERY SYSTEM), MODEL 10003MRNSubstantially EquivalentIno Therapeutics, LLCaccessdata.fda.gov
June 18, 2009K090958INOMAX DS (DELIVERY SYSTEM)MNRSubstantially EquivalentIno Therapeutics, LLCaccessdata.fda.gov
August 28, 2008K081691INOMAX DS (DELIVERY SYSTEM)MRNSubstantially EquivalentIno Therapeutics, LLCaccessdata.fda.gov
August 6, 2008K080484INOMAX DS (DELIVERY SYSTEM), MODEL 10003MRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
October 3, 2007K071516INOMAX DSMRNSubstantially EquivalentIno Therapeutics, LLCaccessdata.fda.gov
April 27, 2007K070867INOMAX DS (DELIVERY SYSTEM), MODEL 10003MRNSubstantially EquivalentIno Therapeutics, LLCaccessdata.fda.gov
December 14, 2006K061901INO THERAPEUTICS INOMAX DS (DELIVERY SYSTEM), MODEL 10003MRNSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
November 4, 2005K052663INO THERAPEUTICS INOBLENDER, MODEL 10004MROSubstantially EquivalentIno Therapeuticsaccessdata.fda.gov
February 10, 2000K000186DATEX-OHMEDA INOVENT DELIVERY SYSTEMMRNSubstantially EquivalentDatex-Ohmedaaccessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
August 8, 202392799Class IOngoingMallinckrodt One-Way Valve, 22F x 22M, a) Part #91346 (1 piece) and b) Part #50412 (pack of 5) Used with ventilators.The One-Way Valve, 22F x 22M may stick and prevent or reduce the flow of ventilated air or oxygen.accessdata.fda.gov
November 21, 201675878Class IITerminatedMallinckrodt Pharmaceuticals INOmax DSIR Plus delivery system. Model 10007. Delivers INOMAX (nitric oxide for inhalation). The INOmax DSIR uses a dual-channel design to ensure the safe delivery of INOMAX. The first channMallinckrodt discovered that some devices may have been manufactured with an out-of-tolerance manometer which can result in in an inaccurate proportional valve calibration table in an affected device.accessdata.fda.gov
January 14, 201570395Class IITerminatedIkaria, INOmax DSIR (Delivery System), Model 10007. Nitric oxide delivery system for use with ventilators.Potential delivery failure alarm condition. INOmax DSIR with software version 2.0.4 and a certain variant of the monitor display may trigger a delivery failure alarm when the display brightness is set to its lowest level. If this condition occurs, therapy will be interrupted.accessdata.fda.gov
October 17, 201469635Class IITerminatedINOMAX DSIR Nitric Oxide delivery system, Model 10007, software version 3.1.0., delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and comprehensive An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.accessdata.fda.gov
March 27, 201467947Class IITerminatedINOmax DSIR, model 10007, Nitric Oxide Delivery System, with Software version 3.0.0. The INOmax DS delivery system delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired An anomaly impacts the monitoring system of INOmax DSIR Plus (software 3.0.0). When the integrated pneumatic backup switch is activated with low or no gas flow through the injector module, an intended NO cell failure alarm will occur. In addition, an unintended NO2 cell failure alarm may also occur. The NO/NO2 cell failure alarms are caused by an average NO/accessdata.fda.gov
November 30, 201060258Not yet classifiedTerminatedINOmax DS (Delivery System) Model 10003 & 10007. The INOMAX DS Delivery System delivers INOMAX (nitric oxide for inhalation) therapy gas into the inspiratory limb of the patient breathing circuit in a way that provides aThrough the review and monitoring of its complaint data, Ikaria identified a product anomaly with the INOmax DS Model 1003. Ikaria concluded the anomaly risk to the patient safety was low and non reportable (4/23/10). During a subsequent Level 3 inspection by FDA, it was concluded that the action should have been reported under 21 CFR & 806.10.accessdata.fda.gov

Compare with other makers

Updated December 6, 2023. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.